{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:08:52Z","timestamp":1794344932953,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0686"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0686"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX0548"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0548"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A critical challenge in glioblastoma multiforme (GBM) treatment is that tumors recurring after temozolomide (TMZ) therapy become more malignant, exhibiting increased invasiveness and stemness compared to the primary tumor. However, the underlying mechanisms remain unclear. While the majority of GBM cells are eradicated by TMZ, a subset enters cell cycle arrest, adopts a senescence-associated secretory phenotype (SASP), and activates senescence-related signaling pathways. These cells eventually escape senescence, re-enter the cell cycle, and form aggregates exhibiting stem-like characteristics such as elevated stemness marker expression, enhanced colony formation, increased invasiveness, and resistance to chemotherapy. Furthermore, these aggregates promote the invasion and chemotherapy resistance of surrounding cells. Gene Set Enrichment Analysis (GSEA) and KEGG pathway analysis of miRNA and mRNA sequences revealed activation of hallmark hypoxia and HIF1 signaling pathways. The study demonstrated that HIF1\u03b1 and HIF2\u03b1 expression fluctuates during and after TMZ treatment. Knockout of HIF1\u03b1 and HIF2\u03b1 in GBM cells exposed to TMZ reduced the formation of senescent cells and stem-like aggregates. These findings challenge the efficacy of TMZ therapy by highlighting its role in inducing the process of cellular senescence, thereby contributing to the enhanced stemness and malignancy of recurrent GBM. The regulatory roles of HIF1\u03b1 and HIF2\u03b1 are emphasized, underscoring the necessity of preventing senescent cell formation and inhibiting HIF1\u03b1\/HIF2\u03b1 expression to improve therapeutic outcomes.<\/jats:p>","DOI":"10.1038\/s41419-025-07617-w","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T08:24:03Z","timestamp":1745051043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1\u03b1\/HIF2\u03b1 regulation"],"prefix":"10.1038","volume":"16","author":[{"given":"Pan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaiYan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-2791","authenticated-orcid":false,"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"7617_CR1","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1111\/cns.13956","volume":"28","author":"B Chen","year":"2022","unstructured":"Chen B, Zhou XX, Yang LT, Zhou HS, Meng M, Wu H, et al. Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment. CNS Neurosci Ther. 2022;28:2148\u201362.","journal-title":"CNS Neurosci Ther"},{"key":"7617_CR2","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1111\/cas.15773","volume":"114","author":"HB Wu","year":"2023","unstructured":"Wu HB, Guo CC, Wang CY, Xu J, Zheng SY, Duan J, et al. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma. Cancer Sci. 2023;114:2609\u201321.","journal-title":"Cancer Sci"},{"key":"7617_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn1128","volume":"14","author":"C Chen","year":"2022","unstructured":"Chen C, Jing WQ, Chen Y, Wang GY, Abdalla M, Gao L, et al. Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy. Sci Transl Med. 2022;14:eabn1128.","journal-title":"Sci Transl Med"},{"key":"7617_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2016.105","volume":"3","author":"P Wang","year":"2017","unstructured":"Wang P, Wan WW, Xiong SL, Feng H, Wu N. Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discov. 2017;3:16105.","journal-title":"Cell Death Discov"},{"key":"7617_CR5","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41419-020-03150-0","volume":"11","author":"P Wang","year":"2020","unstructured":"Wang P, Yan Q, Liao B, Zhao L, Xiong SL, Wang JW, et al. The HIF1\u03b1\/HIF2\u03b1-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions. Cell Death Dis. 2020;11:992.","journal-title":"Cell Death Dis"},{"key":"7617_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5483\/BMBRep.2014.47.2.005","volume":"47","author":"MY Lee","year":"2014","unstructured":"Lee MY, Lee JS. Exploiting tumor cell senescence in anticancer therapy. BMB Rep. 2014;47:51\u201359.","journal-title":"BMB Rep"},{"key":"7617_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/0008-5472.CAN-18-1733","volume":"79","author":"D Aasland","year":"2019","unstructured":"Aasland D, G\u00f6tzinger L, Hauck L, Berte N, Meyer J, Effenberger M, et al. Temozolomide induces senescence and repression of DNA repair pathways in glioblastoma cells via activation of ATR-CHK1, p21, and NF-\u03baB. Cancer Res. 2019;79:99\u2013113.","journal-title":"Cancer Res"},{"key":"7617_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.bjc.6600711","volume":"88","author":"W G\u00fcnther","year":"2003","unstructured":"G\u00fcnther W, Pawlak E, Damasceno R, Arnold H, Terzis AJ. Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Br J Cancer. 2003;88:463\u20139.","journal-title":"Br J Cancer"},{"key":"7617_CR9","doi-asserted-by":"publisher","first-page":"e55665","DOI":"10.1371\/journal.pone.0055665","volume":"8","author":"AV Knizhnik","year":"2013","unstructured":"Knizhnik AV, Roos WP, Nikolova T, Quiros S, Tomaszowski KH, Christmann M, et al. Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage. PloS one. 2013;8:e55665.","journal-title":"PloS one"},{"key":"7617_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.semcancer.2020.12.010","volume":"81","author":"T Saleh","year":"2022","unstructured":"Saleh T, Carpenter VJ, Bloukh S, Gewirtz DA. Targeting tumor cell senescence and polyploidy as potential therapeutic strategies. Semin Cancer Biol. 2022;81:37\u201347.","journal-title":"Semin Cancer Biol"},{"key":"7617_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216843","volume":"590","author":"S Patra","year":"2024","unstructured":"Patra S, Naik PP, Mahapatra KK, Alotaibi MR, Patil S, Patro BS, et al. Recent advancement of autophagy in polyploid giant cancer cells and its interconnection with senescence and stemness for therapeutic opportunities. Cancer Lett. 2024;590:216843.","journal-title":"Cancer Lett"},{"key":"7617_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/cdd.2014.31","volume":"21","author":"B Auffinger","year":"2014","unstructured":"Auffinger B, Tobias AL, Han Y, Lee G, Guo D, Dey M, et al. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. Cell Death Differ. 2014;21:1119\u201331.","journal-title":"Cell Death Differ"},{"key":"7617_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41419-021-03598-8","volume":"12","author":"P Wang","year":"2021","unstructured":"Wang P, Zhao L, Gong S, Xiong SL, Wang JW, Zou DW, et al. HIF1\u03b1\/HIF2\u03b1-Sox2\/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K\/AKT signalling pathway with positive feedback under hypoxia. Cell Death Dis. 2021;12:312.","journal-title":"Cell Death Dis"},{"key":"7617_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/REP-09-0300","volume":"139","author":"CE Forristal","year":"2010","unstructured":"Forristal CE, Wright KL, Hanley NA, Oreffo RO, Houghton FD. Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction. 2010;139:85\u201397.","journal-title":"Reproduction"},{"key":"7617_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109757","volume":"36","author":"HQ Lu","year":"2021","unstructured":"Lu HQ, Lyu YJ, Tran L, Lan J, Xie YY, Yang YK, et al. HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells. Cell Rep. 2021;36:109757.","journal-title":"Cell Rep"},{"key":"7617_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-015-0119-3","volume":"8","author":"X Yin","year":"2015","unstructured":"Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ, Wu WZ, et al. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3\/Snail signaling. J Hematol Oncol. 2015;8:1\u201313.","journal-title":"J Hematol Oncol"},{"key":"7617_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.23","volume":"2","author":"M Herreros-Villanueva","year":"2013","unstructured":"Herreros-Villanueva M, Zhang JS, Koenig A, Abel EV, Smyrk TC, Bamlet WR, et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis. 2013;2:e61.","journal-title":"Oncogenesis"},{"key":"7617_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/jca.54402","volume":"13","author":"P Wang","year":"2022","unstructured":"Wang P, Gong S, Liao B, Pan JY, Wang JW, Zou DW, et al. HIF1\u03b1\/HIF2\u03b1 induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions. J Cancer. 2022;13:1\u201314.","journal-title":"J Cancer"},{"key":"7617_CR19","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garc\u00eda-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543\u2013D552.","journal-title":"Nucleic Acids Res"},{"key":"7617_CR20","doi-asserted-by":"publisher","first-page":"e0238238","DOI":"10.1371\/journal.pone.0238238","volume":"15","author":"RO Minea","year":"2020","unstructured":"Minea RO, Duc TC, Swenson SD, Cho HY, Huang M, Hartman H, et al. Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas. PloS one. 2020;15:e0238238.","journal-title":"PloS one"},{"key":"7617_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/bit.27219","volume":"117","author":"PS Nakod","year":"2020","unstructured":"Nakod PS, Kim Y, Rao SS. Three-dimensional biomimetic hyaluronic acid hydrogels to investigate glioblastoma stem cell behaviors. Biotechnol Bioeng. 2020;117:511\u201322.","journal-title":"Biotechnol Bioeng"},{"key":"7617_CR22","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/neuonc\/not104","volume":"15","author":"C Riganti","year":"2013","unstructured":"Riganti C, Salaroglio IC, Caldera V, Campia I, Kopecka J, Mellai M, et al. Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a\/glycogen synthase-3 kinase\/\u03b2-catenin pathway. Neuro-Oncol. 2013;15:1502\u201317.","journal-title":"Neuro-Oncol"},{"key":"7617_CR23","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1158\/0008-5472.CAN-07-6878","volume":"68","author":"D Beier","year":"2008","unstructured":"Beier D, R\u00f6hrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res. 2008;68:5706\u201315.","journal-title":"Cancer Res"},{"key":"7617_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.gendis.2015.02.001","volume":"2","author":"AR Safa","year":"2015","unstructured":"Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K. Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes Dis. 2015;2:152\u201363.","journal-title":"Genes Dis"},{"key":"7617_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-0716-0759-6_3","volume":"2174","author":"AG Pi\u00f1a-Medina","year":"2021","unstructured":"Pi\u00f1a-Medina AG, Hern\u00e1ndez-Vega AM, D\u00edaz NF, Mancilla-Herrera I, Camacho-Arroyo I. Enrichment and transcriptional characterization of stem cells isolated from human glioblastoma cell lines. Methods Mol Biol. 2021;2174:19\u201329.","journal-title":"Methods Mol Biol"},{"key":"7617_CR26","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.bbagen.2017.07.001","volume":"1861","author":"E Rampazzo","year":"2017","unstructured":"Rampazzo E, Dettin M, Maule F, Scabello A, Calvanese L, D\u2019Auria G, et al. A synthetic BMP-2 mimicking peptide induces glioblastoma stem cell differentiation. Biochim Biophys Acta Gen Subj. 2017;1861:2282\u201392.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"7617_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ccell.2023.02.019","volume":"41","author":"Y Hoogstrate","year":"2023","unstructured":"Hoogstrate Y, Draaisma K, Ghisai SA, van Hijfte L, Barin N, de Heer I, et al. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer cell. 2023;41:678\u201392.e677.","journal-title":"Cancer cell"},{"key":"7617_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41422-021-00528-3","volume":"31","author":"XN Zhang","year":"2021","unstructured":"Zhang XN, Yang KD, Chen C, He ZC, Wang QH, Feng H, et al. Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling. Cell Res. 2021;31:1072\u201387.","journal-title":"Cell Res"},{"key":"7617_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic M, Fan DNY, Belenki D, D\u00e4britz JHM, Zhao Z, Yu Y, et al. Senescence-associated reprogramming promotes cancer stemness. Nature. 2018;553:96\u2013100.","journal-title":"Nature"},{"key":"7617_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"key":"7617_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-92","volume":"13","author":"J Erenpreisa","year":"2013","unstructured":"Erenpreisa J, Cragg MS. Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal. Cancer Cell Int. 2013;13:92.","journal-title":"Cancer Cell Int"},{"key":"7617_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13046-021-02035-0","volume":"40","author":"D Otero-Albiol","year":"2021","unstructured":"Otero-Albiol D, Carnero A. Cellular senescence or stemness: hypoxia flips the coin. J Exp Clin Cancer Res. 2021;40:243.","journal-title":"J Exp Clin Cancer Res"},{"key":"7617_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2020.11.015","volume":"81","author":"E Sikora","year":"2022","unstructured":"Sikora E, Czarnecka-Herok J, Bojko A, Sunderland P. Therapy-induced polyploidization and senescence: coincidence or interconnection?. Semin Cancer Biol. 2022;81:83\u201395.","journal-title":"Semin Cancer Biol"},{"key":"7617_CR34","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1038\/cddis.2012.183","volume":"3","author":"J Cahu","year":"2012","unstructured":"Cahu J, Bustany S, Sola B. Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells. Cell Death Dis. 2012;3:e446.","journal-title":"Cell Death Dis"},{"key":"7617_CR35","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.4161\/cc.8.19.9758","volume":"8","author":"M Sabisz","year":"2009","unstructured":"Sabisz M, Skladanowski A. Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: implications for drug resistance and in vitro drug screening models. Cell Cycle. 2009;8:3208\u201317.","journal-title":"Cell Cycle"},{"key":"7617_CR36","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1158\/1535-7163.MCT-15-0675","volume":"15","author":"G Lee","year":"2016","unstructured":"Lee G, Auffinger B, Guo D, Hasan T, Deheeger M, Tobias AL, et al. Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model. Mol Cancer Ther. 2016;15:3064\u201376.","journal-title":"Mol Cancer Ther"},{"key":"7617_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2014.07.048","volume":"354","author":"YH Kim","year":"2014","unstructured":"Kim YH, Yoo KC, Cui YH, Uddin N, Lim EJ, Kim MJ, et al. Radiation promotes malignant progression of glioma cells through HIF-1alpha stabilization. Cancer Lett. 2014;354:132\u201341.","journal-title":"Cancer Lett"},{"key":"7617_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neuropharm.2014.05.009","volume":"89","author":"ZH Luo","year":"2015","unstructured":"Luo ZH, Bai MH, Xiao X, Zhang W, Liu XD, Yang XL, et al. Silencing of HIF-1\u03b1 enhances the radiation sensitivity of human glioma growth in vitro and in vivo. Neuropharmacology. 2015;89:168\u201374.","journal-title":"Neuropharmacology"},{"key":"7617_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.841017","volume":"10","author":"D Dietrichs","year":"2022","unstructured":"Dietrichs D, Grimm D, Sahana J, Melnik D, Corydon TJ, Wehland M, et al. Three-dimensional growth of prostate cancer cells exposed to simulated microgravity. Front Cell Dev Biol. 2022;10:841017.","journal-title":"Front Cell Dev Biol"},{"key":"7617_CR40","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.3390\/ijms21124509","volume":"21","author":"I Bednarz-Misa","year":"2020","unstructured":"Bednarz-Misa I, Fortuna P, Diakowska D, Jamrozik N, Krzystek-Korpacka M. Distinct local and systemic molecular signatures in the esophageal and gastric cancers: possible therapy targets and biomarkers for gastric cancer. Int J Mol Sci. 2020;21:4509.","journal-title":"Int J Mol Sci"},{"key":"7617_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12964-017-0172-3","volume":"15","author":"P Ortiz-Montero","year":"2017","unstructured":"Ortiz-Montero P, Londo\u00f1o-Vallejo A, Vernot JP. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence\/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun Signal. 2017;15:17.","journal-title":"Cell Commun Signal"},{"key":"7617_CR42","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s12276-021-00717-5","volume":"53","author":"SS Park","year":"2021","unstructured":"Park SS, Choi YW, Kim JH, Kim HS, Park TJ. Senescent tumor cells: an overlooked adversary in the battle against cancer. Exp Mol Med. 2021;53:1834\u201341.","journal-title":"Exp Mol Med"},{"key":"7617_CR43","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2014.9.FOCUS14496","volume":"37","author":"M Womeldorff","year":"2014","unstructured":"Womeldorff M, Gillespie D, Jensen RL. Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus. 2014;37:E8.","journal-title":"Neurosurg Focus"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07617-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07617-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07617-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T09:02:05Z","timestamp":1745053325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07617-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7617"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07617-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was done in compliance with the principles of the Declaration of Helsinki. Ethical related to GBM tissues were approved by the ethics committee of Chongqing General Hospital (No. KY S2022-094-01) and the informed consent was obtained from the patients. All the animal procedures were approved by the ethics committee of ChongQing Medical University (No. IACUC-CQMU-2023-0167).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"317"}}